ABVC BioPharma, Inc. Notes Payable to Bank, Current
ABVC BioPharma, Inc. (ABVC) had Notes Payable to Bank, Current of $107.40 thousand as of 2021-06-30, per its 10-Q filed 2021-08-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:NotesPayableToBankCurrent · last filed 2022-03-31
- 2021-06-30: Notes Payable to Bank, Current $107.40K.
- 2021-03-31: Notes Payable to Bank, Current $105.30K.
- 2020-12-31: Notes Payable to Bank, Current $106.80K.
- 2020-09-30: Notes Payable to Bank, Current $126.92K.
| Period end | Notes Payable to Bank, Current |
|---|---|
| 2021-06-30 | $107.40K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $105.30K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $106.80K 10-K · filed 2022-03-31 |
| 2020-09-30 | $126.92K 10-Q · filed 2020-11-17 |
| 2020-06-30 | $147.52K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $99.30K 10-Q · filed 2020-06-29 |
| 2019-12-31 | $100.20K 10-K · filed 2021-03-16 |